These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2907751

  • 1. Characterization of the receptor binding profile of (3H)-dermorphin in the rat brain.
    Amiche M, Sagan S, Mor A, Delfour A, Nicolas P.
    Int J Pept Protein Res; 1988 Dec; 32(6):506-11. PubMed ID: 2907751
    [Abstract] [Full Text] [Related]

  • 2. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M, Sagan S, Mor A, Pelaprat D, Rostene W, Delfour A, Nicolas P.
    Eur J Biochem; 1990 May 20; 189(3):625-35. PubMed ID: 2161761
    [Abstract] [Full Text] [Related]

  • 3. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M, Sagan S, Mor A, Delfour A, Nicolas P.
    Mol Pharmacol; 1989 Jun 20; 35(6):774-9. PubMed ID: 2543911
    [Abstract] [Full Text] [Related]

  • 4. Characterization of dermorphin binding to membranes of rat brain and heart.
    Krumins SA.
    Neuropeptides; 1987 Jun 20; 9(2):93-102. PubMed ID: 3033543
    [Abstract] [Full Text] [Related]

  • 5. Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors.
    Lazarus LH, Wilson WE, de Castiglione R, Guglietta A.
    J Biol Chem; 1989 Feb 25; 264(6):3047-50. PubMed ID: 2563375
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A, Lewis ME, Khachaturian H, Akil H, Watson SJ.
    Brain Res; 1986 Dec 03; 399(1):69-79. PubMed ID: 3026574
    [Abstract] [Full Text] [Related]

  • 7. Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion.
    Lazarus LH, Guglietta A, Wilson WE, Irons BJ, de Castiglione R.
    J Biol Chem; 1989 Jan 05; 264(1):354-62. PubMed ID: 2562839
    [Abstract] [Full Text] [Related]

  • 8. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY, Li SX, Wheeler-Aceto H, Cowan A.
    Eur J Pharmacol; 1991 Oct 15; 203(2):195-202. PubMed ID: 1666046
    [Abstract] [Full Text] [Related]

  • 9. Stress prevents the chronic ethanol-induced delta opiod receptor supersensitivity in the rat brain.
    Przewłocka B, Lasoń W.
    Pol J Pharmacol Pharm; 1990 Oct 15; 42(2):137-42. PubMed ID: 2177189
    [Abstract] [Full Text] [Related]

  • 10. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA, Houghten R, Pasternak GW.
    Mol Pharmacol; 1988 Sep 15; 34(3):308-17. PubMed ID: 2901663
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM, Mishra RK.
    Mol Pharmacol; 1987 Jul 15; 32(1):109-18. PubMed ID: 3037297
    [Abstract] [Full Text] [Related]

  • 12. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ, Toth G, Gehrig CA, Kao LF, Knapp R, Lui GK, Yamamura HI, Kramer TH, Davis P, Burks TF.
    J Med Chem; 1991 Jun 15; 34(6):1823-30. PubMed ID: 1648137
    [Abstract] [Full Text] [Related]

  • 13. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
    Cotton R, Kosterlitz HW, Paterson SJ, Rance MJ, Traynor JR.
    Br J Pharmacol; 1985 Apr 15; 84(4):927-32. PubMed ID: 2988685
    [Abstract] [Full Text] [Related]

  • 14. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
    Wang XJ, Han JS.
    J Neurochem; 1990 Oct 15; 55(4):1379-82. PubMed ID: 2168937
    [Abstract] [Full Text] [Related]

  • 15. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
    Delay-Goyet P, Ruiz-Gayo M, Baamonde A, Gacel G, Morgat JL, Roques BP.
    Pharmacol Biochem Behav; 1991 Jan 15; 38(1):155-62. PubMed ID: 1850135
    [Abstract] [Full Text] [Related]

  • 16. Structural requirements for dermorphin opioid receptor binding.
    Amiche M, Delfour A, Nicolas P.
    Int J Pept Protein Res; 1988 Jul 15; 32(1):28-34. PubMed ID: 2906053
    [Abstract] [Full Text] [Related]

  • 17. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar 15; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 18. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K, Gee KW, Mosberg HI, Hruby VJ, Yamamura HI.
    Proc Natl Acad Sci U S A; 1985 Apr 15; 82(8):2543-7. PubMed ID: 2986120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP, Kwiat G, Lee NM.
    Eur J Pharmacol; 1989 Jan 02; 159(1):83-8. PubMed ID: 2540013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.